Nosocomial infections in leukemic and solid-tumor cancer patients: Distribution, outcome and microbial spectrum of anaerobes

Future Microbiology

Volumn 7, Issue 12, 2012, Pages 1423-1429

  El Sharif, Amany ^a   Elkhatib, Walid F ^b,c,d   Ashour, Hossam M ^e,f  

^a Al Azhar University   (Egypt)

^b Ain Shams University   (Egypt)

^c HAMPTON UNIVERSITY   (United States)

^d EASTERN VIRGINIA MEDICAL SCHOOL   (United States)

^e CAIRO UNIVERSITY   (Egypt)

^f WAYNE STATE UNIVERSITY   (United States)

Author keywords

anaerobes; leukemia; mortality; neutropenia

Indexed keywords

ANAEROBE; ARTICLE; BACTERIUM ISOLATE; BLOODSTREAM INFECTION; CANCER MORTALITY; CANCER PATIENT; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; EGGERTHELLA LENTA; EUBACTERIUM LIMOSUM; FUSOBACTERIUM NECROPHORUM; GASTROINTESTINAL INFECTION; HOSPITAL INFECTION; HUMAN; LEUKEMIA; MICROBIAL IDENTIFICATION; NEUTROPENIA; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; SKIN INFECTION; SOLID TUMOR; URINARY TRACT INFECTION; VEILLONELLA PARVULA;

BACTERIA, ANAEROBIC; BACTERIAL INFECTIONS; CROSS INFECTION; GASTROENTERITIS; HUMANS; IMMUNOCOMPROMISED HOST; NEOPLASMS; RESPIRATORY TRACT INFECTIONS; SEPSIS; SKIN DISEASES, BACTERIAL; SURVIVAL ANALYSIS; TREATMENT OUTCOME; URINARY TRACT INFECTIONS;

CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM PERFRINGENS; EGGERTHELLA LENTA; EUBACTERIUM LIMOSUM; FUSOBACTERIUM NECROPHORUM; VEILLONELLA PARVULA;

EID: 84870980990     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.12.125     Document Type: Article

References (42)

1. Andrei A, Zervos MJ. The application of molecular techniques to the study of hospital infection. Arch. Pathol. Lab. Med. 130(5), 662-668 (2006).
2. Sable CA, Donowitz GR. Infections in bone marrow transplant recipients. Clin. Infect. Dis. 18(3), 273-281; quiz 282-274 (1994).
3. Cordonnier C. [Nosocomial infections in neutropenic patients]. Rev. Prat. 39(16), 1403-1408 (1989).
4. Briedigkeit H, Gobel U. [Anaerobic bacteria as the cause of endogenous infections]. Z. Arztl. Fortbild. Qualitatssich. 91(2), 165-170 (1997).
5. Willis AT. Treatment of anaerobic infections. Scand. J. Gastroenterol. 90, 53-64 (1984).
6. Finegold SM. Host factors predisposing to anaerobic infections. FEMS Immunol. Med. Microbiol. 6(2-3), 159-163 (1993).
7. Zahar JR, Farhat H, Chachaty E, Meshaka P, Antoun S, Nitenberg G. Incidence and clinical significance of anaerobic bacteraemia in cancer patients: A 6-year retrospective study. Clin. Microbiol. Infect. 11(9), 724-729 (2005).
8. Vidal AM, Sarria JC, Kimbrough RC 3rd, Keung YK. Anaerobic bacteremia in a neutropenic patient with oral mucositis. Am. J. Med. Sci. 319(3), 189-190 (2000).
9. Mrazova-Studena M, Drgona L, Spanik S et al. Bacteremia in neutropenic versus nonneutropenic cancer patients: Etiology and outcome in 401 episodes. Neoplasma 44(5), 314-318 (1997).
10. Spanik S, Trupl J, Kunova A et al. Bloodstream infections due to anaerobic bacteria in cancer patients: Epidemiology, etiology, risk factors, clinical presentation and outcome of anaerobic bacteremia. Neoplasma 43(4), 235-238 (1996).
11. Wisplinghoff H, Cornely OA, Moser S et al. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: A prospective cohort and matched case-control study. Infect. Control Hosp. Epidemiol. 24(12), 905-911 (2003).
12. Valles J, Leon C, Alvarez-Lerma F. Nosocomial bacteremia in critically ill patients: A multicenter study evaluating epidemiology and prognosis. Spanish Collaborative Group for Infections in Intensive Care Units of Sociedad Espanola de Medicina Intensiva y Unidades Coronarias (SEMIUC). Clin. Infect. Dis. 24(3), 387-395 (1997).
13. Weinstein MP, Towns ML, Quartey SM et al. The clinical significance of positive blood cultures in the 1990s: A prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin. Infect. Dis. 24(4), 584-602 (1997).
14. Carlisle PS, Gucalp R, Wiernik PH. Nosocomial infections in neutropenic cancer patients. Infect. Control Hosp. Epidemiol. 14(6), 320-324 (1993).
15. Mortlock S. Bacteraemia among patients attending a cancer hospital in Lahore, Pakistan. Br. J. Biomed. Sci. 57(2), 119-125 (2000).
16. Marchetti O, Calandra T. Infections in neutropenic cancer patients. Lancet 359(9308), 723-725 (2002).
17. Madani TA. Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia. Infection 28(6), 367-373 (2000).
18. Gaytan-Martinez J, Mateos-Garcia E, Sanchez- Cortes E, Gonzalez-Llaven J, Casanova-Cardiel LJ, Fuentes-Allen JL. Microbiological findings in febrile neutropenia. Arch. Med. Res. 31(4), 388-392 (2000).
19. Berrouane YF, McNutt LA, Buschelman BJ et al. Outbreak of severe Pseudomonas aeruginosa infections caused by a contaminated drain in a whirlpool bathtub. Clin. Infect. Dis. 31(6), 1331-1337 (2000).
20. Rolston KV. The spectrum of pulmonary infections in cancer patients. Curr. Opin. Oncol. 13(4), 218-223 (2001).
21. Rybojad P, Los R, Sawicki M, Tabarkiewicz J, Malm A. Anaerobic bacteria colonizing the lower airways in lung cancer patients. Folia Histochem. Cytobiol. 49(2), 263-266 (2011).
22. Korona-Glowniak I, Los R, Rybojad P, Sawicki M, Malm A. Bacterial colonization of pleural drains in patients with lung cancer: An analysis of risk factors. Med. Sci. Monit. 16(2), CR84-CR91 (2010).
23. Tager FM, Zolezzi RP, Folatre BI, Navarrete CM, Rojas PJ. [Respiratory virus infections in children with acute lymphoblastic leukemia and febrile neutropenia: A prospective study]. Rev. Chilena Infectol. 23(2), 118-123 (2006).
24. Subira M, Martino R, Franquet T et al. Invasive pulmonary aspergillosis in patients with hematologic malignancies: Survival and prognostic factors. Haematologica 87(5), 528-534 (2002).
25. Gross PA, Neu HC, Aswapokee P, Van Antwerpen C, Aswapokee N. Deaths from nosocomial infections: Experience in a university hospital and a community hospital. Am. J. Med. 68(2), 219-223 (1980).
26. Goldstein EJ. Anaerobic bacteremia. Clin. Infect. Dis. 23(SUPPL1), S97-S101 (1996).
27. Bouza E, Reig M, Garcia De La Torre M et al. Retrospective analysis of two hundred and twelve cases of bacteremia due to anaerobic microorganisms. Eur. J. Clin. Microbiol. 4(3), 262-267 (1985).
28. Rodrigo Tapia JP, Alvarez Mendez JC, Suarez Nieto C, Gomez Martinez J, Fernandez Martinez JA, Martinez Sanchez JA. [Bacteriology of surgical wound infections in oncological head and neck surgery]. Acta Otorrinolaringol. Esp. 48(5), 389-391 (1997).
29. Brook I. Bacteria from solid tumours. J. Med. Microbiol. 32(3), 207-210 (1990).
30. Venglarcik J. Lemierre's syndrome. Pediatr. Infect Dis. J. 22(10), 921-923 (2003).
31. Fanourgiakis P, Vekemans M, Georgala A et al. Febrile neutropenia and Fusobacterium bacteremia: Clinical experience with 13 cases. Support. Care Cancer 11(5), 332-335 (2003).
32. Brook I, Frazier EH. The aerobic and anaerobic bacteriology of perirectal abscesses. J. Clin. Microbiol. 35(11), 2974-2976 (1997).
33. Sakamoto K, Konishi K. Antitumor effect of normal intestinal microflora on Ehrlich ascites tumor. Jpn J. Cancer Res. 79(1), 109-116 (1988).
34. Morinaga S, Sakamoto K, Konishi K. Antitumor activity and its properties of Eubacterium lentum. Jpn J. Cancer Res. 79(1), 117-124 (1988).
35. Sauvage C, Dreyfus F, Vedel G, Watine J. Clostridium perfringens septicemia during the course of leukemia. Nouv. Rev. Fr. Hematol. 34(4), 345-346 (1992).
36. Grunewald T, Frenzel S, Decker M et al. Nosocomial epidemiology and transmission of Clostridium difficile infection. Dtsch Med. Wochenschr. 126(18), 519-522 (2001).
37. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch. Surg. 142(7), 624-631; discussion 631 (2007).
38. Garcia C, Samalvides F, Vidal M, Gotuzzo E, Dupont HL. Epidemiology of Clostridium difficile associated diarrhea in a Peruvian tertiary care hospital. Am. J. Trop. Med. Hyg. 77(5), 802-805 (2007).
39. Winkeljohn D. Clostridium difficile infection in patients with cancer. Clin. J. Oncol. Nurs. 15(2), 215-217 (2011).
40. Tai E, Richardson LC, Townsend J, Howard E, McDonald LC. Clostridium difficile infection among children with cancer. Pediatr. Infect. Dis. J. 30(7), 610-612 (2011).
41. Barbut F, Petit JC. Epidemiology of Clostridium difficile-Associated infections. Clin. Microbiol. Infect. 7(8), 405-410 (2001).
42. Wilcox MH, Cunniffe JG, Trundle C, Redpath C. Financial burden of hospital-Acquired Clostridium difficile infection. J. Hosp. Infect. 34(1), 23-30 (1996).